Scholars Central

Conference abstractPublished 25 Apr 2022

Hormone receptor-positive/HER2-negative mBC A brief overview of disease management from a nursing perspective

Authors: Jessie Desir

University of Miami, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Breast cancer (BC) represents the most frequent cancer in women and the second cause of cancer deaths worldwide. Breast cancer is the most diagnosed cancer in the United States, and its incidence rates cannot go unrecognized, especially in younger women. The human immune cells play a dual role during cancer onset and progression, contributing to tumor escape. The earlier breast cancer is diagnosed and staged, the better the chance of surviving five years after being diagnosed. BC progression is a complex process controlled by receptors that coordinate the control of tumor cells growth. Breast cancer subtypes differ in presentation, response to treatment, and outcomes. Identifying the breast cancer stage, pathology, subtype, and mutational status informs treatment options. The determination of breast cancer staging confirms the extent of the disease. The treatment strategy is to understand and know the stage, pathology, receptor status, and mutational status. Hormone receptor-positive (HR+), human epidermal growth factor receptor 2–negative (HER2-) is the most common breast cancer subtype accounting for nearly 70% of breast cancers. This presentation aims to provide a brief overview of HR+/HER2- disease management from a nursing perspective in patient management.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectDiabetes & Endocrinology
  • SubjectNursing & Healthcare
  • BylineArticles whose byline prints “Jessie Desir”